{"entity":{"id":"ijrobp","kind":"journal","name":"International Journal of Radiation Oncology, Biology, Physics","aka":["IJROBP","Int J Radiat Oncol Biol Phys","The Red Journal"],"tldr":"The International Journal of Radiation Oncology, Biology, Physics, known as the Red Journal, is the American Society for Radiation Oncology's journal and the main US venue for radiotherapy trials, dose and fractionation evidence, physics and toxicity research, including NRG and RTOG cooperative-group results. Access is hybrid.","summary":"The International Journal of Radiation Oncology, Biology, Physics (IJROBP), known as the Red Journal, is the journal of the American Society for Radiation Oncology (ASTRO), founded in 1975 and published by Elsevier on a hybrid access model. It is the main US venue for radiation oncology trials, dose-fractionation evidence, physics and toxicity research, publishing NRG and RTOG cooperative-group trials, stereotactic and hypofractionation studies, radiobiology and ASTRO clinical practice guidelines, with the ASTRO annual meeting abstracts as a supplement. Its readers are radiation oncologists, physicists and radiobiologists. Within OnCo it is related to the ASTRO Annual Meeting source and linked from the Albert Koong and Anthony Zietman biographies.","asOf":"2026-09-09","links":[{"label":"ASTRO","url":"https://www.astro.org"}],"tags":[],"related":["src-astro"],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"publisher":"Elsevier","url":"https://www.redjournal.org","issn":"0360-3016","scope":"radiation oncology","access":"hybrid","founded":1975,"matchNames":["International Journal of Radiation Oncology, Biology, Physics","International Journal of Radiation Oncology Biology Physics","IJROBP","Int J Radiat Oncol Biol Phys"],"society":"American Society for Radiation Oncology"},"route":"/journals/ijrobp/","neighbours":{"collection":[{"id":"src-astro","kind":"collection","name":"ASTRO Annual Meeting","route":"/collections/src-astro/"}],"person":[{"id":"albert-koong","kind":"person","name":"Albert C. Koong","route":"/people/albert-koong/"},{"id":"anthony-zietman","kind":"person","name":"Anthony L. Zietman","route":"/people/anthony-zietman/"}],"paper":[{"id":"paper-voss-int-j-radiat-oncol-biol-phys","kind":"paper","name":"ERGO2: A Prospective, Randomized Trial of Calorie-Restricted Ketogenic Diet and Fasting in Addition to Reirradiation for Malignant Glioma","route":"/key-papers/paper-voss-int-j-radiat-oncol-biol-phys/"},{"id":"paper-jaffray-int-j-radiat-oncol-biol-phys","kind":"paper","name":"Flat-panel cone-beam computed tomography for image-guided radiation therapy","route":"/key-papers/paper-jaffray-int-j-radiat-oncol-biol-phys/"},{"id":"paper-convert-int-j-radiat-oncol-biol-phys-2024-update","kind":"paper","name":"Long-Term Outcomes After Concurrent Once- or Twice-Daily Chemoradiation in Limited-Stage Small Cell Lung Cancer: A Brief Report From the CONVERT Trial","route":"/key-papers/paper-convert-int-j-radiat-oncol-biol-phys-2024-update/"},{"id":"paper-partiqol-astro-2024","kind":"paper","name":"PARTIQoL: phase 3 randomised trial of proton therapy versus IMRT for localised prostate cancer (ASTRO 2024 late-breaking abstract)","route":"/key-papers/paper-partiqol-astro-2024/"},{"id":"paper-nagata-int-j-radiat-oncol-biol-phys","kind":"paper","name":"Prospective Trial of Stereotactic Body Radiation Therapy for Both Operable and Inoperable T1N0M0 Non-Small Cell Lung Cancer: Japan Clinical Oncology Group Study JCOG0403","route":"/key-papers/paper-nagata-int-j-radiat-oncol-biol-phys/"},{"id":"paper-bentzen-int-j-radiat-oncol-biol-phys","kind":"paper","name":"Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): an introduction to the scientific issues","route":"/key-papers/paper-bentzen-int-j-radiat-oncol-biol-phys/"}]}}